A new study argues that prolonged chemotherapy decreases the development of new brain cells, and disrupts ongoing brain rhythms in the part of the brain responsible for making new memories.
Recurrent gliomas could have genetic profiles which are different from those of the initial tumors that spawned them, a new study reports.
Researchers suggest delivering chemotherapy directly into the brain cavity could offer a better way to treat tumors which have metastasized to the brain.
Researchers report a combination of three different anti-cancer drugs shows promising results for the treatment of glioblastoma brain cancer.
Researchers have discovered a way in which to sensitize drug-resistant human glioblastoma cells to chemotherapy.
A lipid nanocarrier small enough to pass the blood-brain barrier could be an effective method for delivering chemotherapy medications to help fight glioblastoma brain tumors, a new study reports.
Temozolomide, a chemotherapy drug used to treat brain cancer, could increase risks of developing depression by preventing neurogenesis, a new study reports.
Arsenic trioxide, a treatment used for acute promyelocytic leukemia, may help extend lifespan in patients with glioblastoma brain cancer, a new study reports.
Researchers report the addition of an FDA approved chemotherapy drug called hydroxyyurea to temozolomide helps to increase survival rates in animal models of glioblastoma.
